Hearing:
Full Committee hearing “Limitless Surveillance at the FDA: Protecting the Rights of Federal Whistleblowers“
Committee on Oversight and Government Reform
Wednesday, February 26, 2014 (10:00 AM)
2154 RHOB
Washington, D.C.
Witnesses
The Honorable Charles E. Grassley
United States Senator, Iowa
Added
02/26/2014 at 05:15 PM
- Grassley Statement
[PDF]
Added
02/26/2014 at 05:23 PM
Ms. Angela Canterbury
Director of Public Policy, Project on Government Oversight
Added
02/26/2014 at 05:15 PM
- Canterbury Statement
[PDF]
Added
02/26/2014 at 05:23 PM
- Canterbury Truth in Testimony
[PDF]
Added
02/26/2014 at 05:23 PM
- Canterbury Biography
[PDF]
Added
02/26/2014 at 05:23 PM
Mr. Walter Harris
Chief Operating Officer and Acting Chief Information Officer, U.S. Food and Drug Administration
Added
02/26/2014 at 05:15 PM
- Harris Statement
[PDF]
Added
02/26/2014 at 05:23 PM
- Harris Biography
[PDF]
Added
02/26/2014 at 05:23 PM
Ms. Ruth McKee
Associate Director for Management, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Added
02/26/2014 at 05:15 PM
- McKee Biography
[PDF]
Added
02/26/2014 at 05:23 PM
Dr. Jeffrey Shuren
Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Added
02/26/2014 at 05:15 PM
- Shuren Biography
[PDF]
Added
02/26/2014 at 05:23 PM
Hearing Record
- Hearing Transcript
[PDF]
Added
10/29/2014 at 11:19 AM
First Published:
February 19, 2014 at 05:05 PM
Last Updated:
October 29, 2014 at 11:20 AM